P490: SNORNA-DERIVED RNAS (SDRNAS) ARE IMPORTANT DRIVERS OF LEUKEMOGENESIS AND LEUKEMIC MAINTENANCE IN AML

• R. Zinz,
• C. Rohde,
• D. Heid,
• M. Bruckmann,
• M. Bornhäuser,
• C. Röllig,
• U. Platzbecker,
• C. Baldus,
• H. Serve,
• F. Zhou,
• C. Pabst,
• C. Müller-Tidow,
• M. F. Blank

Affiliations

R. Zinz

1 Medical Department V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital

C. Rohde

1 Medical Department V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital

D. Heid

1 Medical Department V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital

M. Bruckmann

1 Medical Department V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital

M. Bornhäuser

5 Medical Clinic and Policlinic I, University Hospital Carl Gustav Carus and Medical Faculty of the TU Dresden, Dresden

C. Röllig

5 Medical Clinic and Policlinic I, University Hospital Carl Gustav Carus and Medical Faculty of the TU Dresden, Dresden

U. Platzbecker

6 Department of Hematology, Cellular Therapy and Hemostaseology, Leipzig University Hospital, Leipzig

C. Baldus

7 Medical Department II, Hematology/Oncology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel

H. Serve

8 Department of Medicine II, Hematology/Oncology, University Hospital Frankfurt, Goethe-University Frankfurt, Frankfurt

F. Zhou

1 Medical Department V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital

C. Pabst

1 Medical Department V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital

C. Müller-Tidow

1 Medical Department V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital

M. F. Blank

1 Medical Department V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital